Retrospective motion correction through multi-average k-space data elimination (REMAKE) for free-breathing cardiac cine imaging.


Journal

Magnetic resonance in medicine
ISSN: 1522-2594
Titre abrégé: Magn Reson Med
Pays: United States
ID NLM: 8505245

Informations de publication

Date de publication:
06 2023
Historique:
revised: 06 01 2023
received: 06 10 2022
accepted: 20 01 2023
medline: 28 3 2023
pubmed: 11 2 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

To develop a motion-robust reconstruction technique for free-breathing cine imaging with multiple averages. Retrospective motion correction through multiple average k-space data elimination (REMAKE) was developed using iterative removal of k-space segments (from individual k-space samples) that contribute most to motion corruption while combining any remaining segments across multiple signal averages. A variant of REMAKE, termed REMAKE+, was developed to address any losses in SNR due to k-space information removal. With REMAKE+, multiple reconstructions using different initial conditions were performed, co-registered, and averaged. Both techniques were validated against clinical "standard" signal averaging reconstruction in a static phantom (with simulated motion) and 15 patients undergoing free-breathing cine imaging with multiple averages. Quantitative analysis of myocardial sharpness, blood/myocardial SNR, myocardial-blood contrast-to-noise ratio (CNR), as well as subjective assessment of image quality and rate of diagnostic quality images were performed. In phantom, motion artifacts using "standard" (RMS error [RMSE]: 2.2 ± 0.5) were substantially reduced using REMAKE/REMAKE+ (RMSE: 1.5 ± 0.4/1.0 ± 0.4, p < 0.01). In patients, REMAKE/REMAKE+ led to higher myocardial sharpness (0.79 ± 0.09/0.79 ± 0.1 vs. 0.74 ± 0.12 for "standard", p = 0.004/0.04), higher image quality (1.8 ± 0.2/1.9 ± 0.2 vs. 1.6 ± 0.4 for "standard", p = 0.02/0.008), and a higher rate of diagnostic quality images (99%/100% vs. 94% for "standard"). Blood/myocardial SNR for "standard" (94 ± 30/33 ± 10) was higher vs. REMAKE (80 ± 25/28 ± 8, p = 0.002/0.005) and tended to be lower vs. REMAKE+ (105 ± 33/36 ± 12, p = 0.02/0.06). Myocardial-blood CNR for "standard" (61 ± 22) was higher vs. REMAKE (53 ± 19, p = 0.003) and lower vs. REMAKE+ (69 ± 24, p = 0.007). Compared to "standard" signal averaging reconstruction, REMAKE and REMAKE+ provide improved myocardial sharpness, image quality, and rate of diagnostic quality images.

Identifiants

pubmed: 36763898
doi: 10.1002/mrm.29613
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2242-2254

Subventions

Organisme : British Heart Foundation
ID : PG/19/11/34243
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/21/10539
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203148/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.

Références

Circulation. 1987 Jul;76(1):44-51
pubmed: 3594774
Magn Reson Med. 2008 Apr;59(4):771-8
pubmed: 18302227
Magn Reson Med. 2018 Feb;79(2):826-838
pubmed: 28497486
Magn Reson Med. 2001 Feb;45(2):346-8
pubmed: 11180443
Magn Reson Imaging. 2017 May;38:129-137
pubmed: 28034638
Neuroimage. 2009 Mar;45(1 Suppl):S61-72
pubmed: 19041946
Magn Reson Med. 2014 Aug;72(2):347-61
pubmed: 24006292
Open Heart. 2016 Apr 27;3(1):e000388
pubmed: 27158524
Magn Reson Med. 2005 Jan;53(1):194-200
pubmed: 15690519
J Cardiovasc Magn Reson. 2016 Sep 22;18(1):58
pubmed: 27660042
J Cardiovasc Magn Reson. 2013 Nov 14;15:102
pubmed: 24228930
J Comput Assist Tomogr. 2011 May-Jun;35(3):382-6
pubmed: 21586935
J Magn Reson Imaging. 2012 Sep;36(3):511-28
pubmed: 22903653
Magn Reson Med. 2009 Dec;62(6):1557-64
pubmed: 19780155
J Appl Clin Med Phys. 2020 Apr;21(4):68-79
pubmed: 32166850
J Cardiovasc Magn Reson. 2020 Dec 14;22(1):87
pubmed: 33308262
Magn Reson Med. 2015 Nov;74(5):1306-16
pubmed: 25376772
Quant Imaging Med Surg. 2018 Mar;8(2):196-208
pubmed: 29675361
Magn Reson Med. 2018 Jul;80(1):181-189
pubmed: 29222852
Magn Reson Med. 2005 Jan;53(1):159-68
pubmed: 15690515
J Am Coll Cardiol. 2003 Aug 20;42(4):736-42
pubmed: 12932612
AJR Am J Roentgenol. 2019 May;212(5):1024-1029
pubmed: 30835515
J Cardiovasc Magn Reson. 2013 Jun 13;15:51
pubmed: 23763839
J Cardiovasc Magn Reson. 2016 Feb 25;18:10
pubmed: 26915830
Magn Reson Med. 2007 Mar;57(3):606-13
pubmed: 17326164
Magn Reson Med. 2008 Sep;60(3):709-17
pubmed: 18727100
Magn Reson Med. 2008 Mar;59(3):463-8
pubmed: 18306398
Card Fail Rev. 2016 Nov;2(2):115-122
pubmed: 28785465
J Cardiovasc Magn Reson. 2017 Feb 3;19(1):18
pubmed: 28178995
Magn Reson Med. 2019 Aug;82(2):706-720
pubmed: 31006916
Sci Rep. 2020 Aug 13;10(1):13710
pubmed: 32792507
Magn Reson Med. 2012 Sep;68(3):741-50
pubmed: 22190255
Magn Reson Med. 2009 Dec;62(6):1658-64
pubmed: 19902515
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17
pubmed: 32089132
Magn Reson Med. 2013 Jan;69(1):91-102
pubmed: 22392604
Magn Reson Med. 2023 Jun;89(6):2242-2254
pubmed: 36763898
Magn Reson Med. 2000 Dec;44(6):940-6
pubmed: 11108632
J Radiat Res. 2012 Nov 1;53(6):945-53
pubmed: 22966173
Magn Reson Med. 2017 Aug;78(2):472-483
pubmed: 27529745
J Cardiovasc Magn Reson. 2016 Aug 24;18(1):50
pubmed: 27553656
Echo Res Pract. 2019 Oct 1;:
pubmed: 31730044
Magn Reson Med. 2021 May;85(5):2403-2416
pubmed: 33226699
Magn Reson Med. 2014 Nov;72(5):1208-17
pubmed: 25216287
NMR Biomed. 2021 Feb;34(2):e4433
pubmed: 33258197
JACC Cardiovasc Imaging. 2014 Sep;7(9):882-92
pubmed: 25129517
AJR Am J Roentgenol. 2009 May;192(5):1348-58
pubmed: 19380560
Magn Reson Med. 2011 Apr;65(4):1097-102
pubmed: 21413074
Magn Reson Med. 2013 Oct;70(4):1005-15
pubmed: 23132549

Auteurs

Alexander Paul Neofytou (AP)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Radhouene Neji (R)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
MR Research Collaborations, Siemens Healthcare Limited, Newton House, Sir William Siemens Square, Frimley, Camberley, Surrey, UK.

Grzegorz Tomasz Kowalik (GT)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Ronald Mooiweer (R)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
MR Research Collaborations, Siemens Healthcare Limited, Newton House, Sir William Siemens Square, Frimley, Camberley, Surrey, UK.

James Wong (J)

Department of Paediatric Cardiology, Evelina London Children's Hospital, London, UK.

Anastasia Fotaki (A)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Joana Ferreira (J)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Carl Evans (C)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Filippo Bosio (F)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Nabila Mughal (N)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Reza Razavi (R)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Kuberan Pushparajah (K)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Department of Paediatric Cardiology, Evelina London Children's Hospital, London, UK.

Sébastien Roujol (S)

School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH